Golden State Wealth Management LLC Acquires New Position in iShares Biotechnology ETF (NASDAQ:IBB)

Golden State Wealth Management LLC bought a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 969 shares of the financial services provider’s stock, valued at approximately $128,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Strategic Financial Concepts LLC purchased a new position in shares of iShares Biotechnology ETF in the fourth quarter valued at about $1,375,000. Telos Capital Management Inc. raised its stake in iShares Biotechnology ETF by 1.9% during the 4th quarter. Telos Capital Management Inc. now owns 10,999 shares of the financial services provider’s stock valued at $1,454,000 after purchasing an additional 209 shares during the period. Nvwm LLC lifted its holdings in iShares Biotechnology ETF by 96.4% in the 4th quarter. Nvwm LLC now owns 1,493 shares of the financial services provider’s stock worth $197,000 after purchasing an additional 733 shares in the last quarter. Massachusetts Wealth Management bought a new position in iShares Biotechnology ETF in the 4th quarter worth approximately $270,000. Finally, Hager Investment Management Services LLC purchased a new stake in iShares Biotechnology ETF during the 4th quarter valued at approximately $34,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB stock opened at $137.67 on Monday. The company’s fifty day moving average price is $136.22 and its 200-day moving average price is $141.35. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently declared a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.